| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |